Weinberg Eric sold $14K of RXST
Weinberg Eric (See remarks) sold 2,041 shares of RxSight, Inc. (RXST) at $6.96 on 2026-09-02.
How this was made
The 30-second read
Why it matters
The transaction is unlikely to influence RxSight's share price or investor sentiment.
Market read
A small insider sell with minimal trading relevance.
What to watch
Potential upcoming FDA decisions or product launches could later affect the stock, but are unrelated to this filing.
Background
SEC Form 4 filings disclose insider transactions. This filing reports a routine open‑market sale by an officer.
Ticker impact
Officer Eric Weinberg sold 2,041 shares of RxSight for $14,205 on 2026-09-02.
No significant price impact expected.
The sale size ($14k) is trivial relative to market cap and typical insider trading volumes.
Market effects
None; RxSight operates in ophthalmic devices, but the transaction is too small to affect the sector.
None; the filing is U.S.-focused and does not influence broader regional markets.
None; the event is isolated to RxSight.
Counterpoint
If the insider had insider knowledge, a sell could signal concerns, but the amount is too small to be meaningful.
Key entities
- CompanyRxSight, Inc.
U.S. ophthalmic device maker listed on NASDAQ (RXST).
- OfficerEric Weinberg
Company officer who sold shares.
